Skip to content

Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.

Carolina Medeiros da Frota Ribeiro, Patricio Riva-Posse

Current Psychiatry Reports November 15, 2017 DOI: 10.1007/s11920-017-0855-x (opens in new tab)

Read Full Text
Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Review with case reports Peer reviewed
Sample size 2
Population Geriatric patients with treatment-resistant depression
Intervention Ketamine
Topics Depression Ketamine Esketamine
Keywords Antidepressants Elderly Geriatric Resistant
Key findings The authors argue that ketamine is a promising treatment for treatment-resistant depression in older adults, based on a review of the limited literature (five prior case reports) and two new cases in which ketamine led to significant and sustained improvement in depressive symptoms. They call for further studies in this population.

Abstract

The purpose of this paper is to provide a review of the use of ketamine as an antidepressant for treatment-resistant depression (TRD) in the geriatric population. Available treatment options for late-life treatment-resistant depression are limited and include electroconvulsive therapy and transcranial magnetic stimulation as well as possible pharmacologic augmentation. Ketamine has been shown to be a promising treatment in TRD; however, data regarding the use of ketamine in the elderly includes only five case reports. We discuss the use of ketamine for late-life TRD and present two cases where ketamine led to a significant and sustained improvement in depressive symptoms. Ketamine is a promising treatment for geriatric patients with TRD. Further studies in the elderly will provide valuable insights into the use of ketamine for a population much in need of safe and effective treatments for TRD.

Comparable studies

Other case reports and case series on ketamine for depression, most cited first.

Study Year Design Participants
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood. A patient with treatment-resistant depression and comorbid generalized anxiety... 2025 Case report n = 1
Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series Four depressed patients taking standard antidepressants 2009 Case series n = 4
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression Patients with enduring eating disorders and treatment-resistant depression 2021 Case series n = 4
Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series Veterans with co-morbid depression and PTSD 2022 Retrospective case series n = 35
Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa Patients with anorexia nervosa and a comorbid depressive disorder treated at a private... 2023 Case report n = 4

Citations in the library

Cited by 13

and 8 more in the library

Cites 11

and 6 more in the library

Related reading

Explore topics

Depression Ketamine Esketamine

By condition and practice

Ketamine for depression